geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study)


, : Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). American Journal of Cardiology 117(8): 1199-1205

Statins may have nephroprotective as well as cardioprotective effects in patients with cardiovascular disease. In the Treating to New Targets (TNT) study (NCT00327691), patients with coronary heart disease (CHD) were randomized to atorvastatin 10 or 80 mg/day and followed for 4.9 years. The relation between intrastudy change in estimated glomerular filtration rate (eGFR) from baseline and the risk of major cardiovascular events (MCVEs, defined as CHD death, nonfatal non-procedure-related myocardial infarction, resuscitated cardiac arrest, or fatal or nonfatal stroke) was assessed among 9,500 patients stratified by renal function: improving (change in eGFR more than +2 ml/min/1.73 m(2)), stable (-2 to +2 ml/min/1.73 m(2)), and worsening (less than -2 ml/min/1.73 m(2)). Compared with patients with worsening renal function (1,479 patients, 15.6%), the rate of MCVEs was 28% lower in patients with stable renal function (2,241 patients, 23.6%) (hazard ratio [HR] 0.72; 95% confidence interval [CI] 0.60 to 0.87; p = 0.0005) and 64% lower in patients with improving renal function (5,780 patients, 60.8%; HR 0.36; 95% CI 0.30 to 0.43; p <0.0001). For each 1 ml/min/1.73 m(2) increase in eGFR, the absolute reduction in the rate of MCVEs was 2.7% (HR 0.973; 95% CI 0.967 to 0.980; p <0.0001). An absolute MCVE rate reduction per 1 ml/min/1.73 m(2) increase in eGFR of 2.0% was reported with atorvastatin 10 mg and 3.3% with atorvastatin 80 mg. In conclusion, intrastudy stabilization or increase in eGFR in atorvastatin-treated patients with CHD from the TNT study was associated with a reduced rate of MCVEs. Statin-treated CHD patients with progressive renal impairment are at high risk for future cardiovascular events.

US$19.90

PMID: 26940556

DOI: 10.1016/j.amjcard.2016.01.014


Other references

Martínez, L.; Peinado, A.; Liesum, L., 2013: In-line quantification of two active ingredients in a batch blending process by near-infrared spectroscopy: influence of physical presentation of the sample. The aim of this study was to apply near-infrared (NIR) spectroscopy to the simultaneous in-line monitoring of two active pharmaceutical ingredients (APIs) in a pharmaceutical batch blending process. The formulation under study consisted of a high...

Lippmann, S., 1995: Aging topic questions on residency inservice training examinations. Journal of the American Geriatrics Society 43(8): 940-941

Forslund, Bk, 1992: What do we mean by good food quality?. American Association of Bovine Practitioners Conference: proceedings(1): 291-295

Ramensky, V.; Bork, P.; Sunyaev, S., 2002: Human non-synonymous SNPs: Server and survey. Human single nucleotide polymorphisms (SNPs) represent the most frequent type of human population DNA variation. One of the main goals of SNP research is to understand the genetics of the human phenotype variation and especially the genetic basis...

Thalgott, M., 2010: Not Available. Mmw Fortschritte der Medizin 152(41): 40-44

Brem, F.; Hirt, A.M.; Simon, C.; Wieser, H-Gregor.; Dobson, J., 2005: Characterization of iron compounds in tumour tissue from temporal lobe epilepsy patients using low temperature magnetic methods. Excess iron accumulation in the brain has been shown to be related to a variety of neurodegenerative diseases. However, identification and characterization of iron compounds in human tissue is difficult because concentrations are very low. For the...

Iba, T.; Miki, T.; Hashiguchi, N.; Tabe, Y.; Nagaoka, I., 2015: Is the neutrophil a 'prima donna' in the procoagulant process during sepsis?. Activation of the coagulation system is a fundamental host defense mechanism. Microorganisms that have invaded the body are trapped and disposed of in clots. Monocytes/macrophages are widely accepted as the main players in the procoagulant process...

Peters N.E.; Hooper R.P.; Huntington T.G., 1993: The Panola Mountain research watershed; hydrologic and biogeochemical process research, a watershed approach. U S

Metwally, K.; Pratsinis, H.; Kletsas, D., 2017: Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation. Two thiazolidinedione scaffolds different in the position of the thiazolidinedione ring in the molecule were tested for in vitro cytotoxic activity in a panel of human cancer cell lines namely, prostate cancer cells PC-3, breast carcinoma cells M...

Scheidegger, H.U., 1981: Executive agencies for occupational law and their contribution to work safety. The legislation and its execution in the field of work safety is still characterized today by a dualism between the sickness and accident insurance laws (which are executed primarily by the Swiss National Accident Insurance Fund) and the employmen...